REVIEW PAPER
Prostaglandins in the induction of labour – do we have the optimal
substance, dose, and route of administration? Literature review
1
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Head of the Collegium: Prof. Marianna Janion
2
Clinic of Obstetrics and Gynaecology, Provincial Combined Hospital, Kielce, Poland
Head of the Clinic: Grzegorz Świercz PhD
3
Clinic of Neonatology, Provincial Combined Hospital, Kielce, Poland
Head of the Clinic: Grażyna Pazera MD
Submission date: 2020-10-30
Final revision date: 2021-03-13
Acceptance date: 2021-04-07
Publication date: 2021-06-30
Medical Studies 2021;37(2):162-167
KEYWORDS
TOPICS
ABSTRACT
Induction of labour (IOL) is a procedure that reduces mortality and morbidity of the mother and the newborn in particular clinical settings. Currently the number of indications for this procedure is increasing; at the same time, intensive work is underway to optimize IOL in terms of duration, obstetric results, and costs. There are no universal standards regarding the optimal way to pre-induce patients in the case of unfavourable cervix, but prostaglandin analogues play an important role in this process. In this paper we discuss the physiological role of prostaglandins and review the current evidence-based literature on this topic, trying to find optimal substance, dose, and route of administration in pre-induction of labour in terms of effectiveness, obstetrical outcomes, and intrapartum complications.
REFERENCES (33)
1.
World Health Organization Dept. of Reproductive Health and Research. WHO recommendations for induction of labour. 2011, https://www.who.int/reproducti....
2.
Grobman WA, Rice MM, Reddy UM, Tita ATN, Silver RM. Labor induction versus expectant management in low-risk nulliparous women. N Engl J Med 2018; 379: 513-523.
3.
Committee. Society of Maternal-Fetal (SMFM) Publications. SMFM Statement on Elective Induction of Labor in Low-Risk Nulliparous Women at Term: the ARRIVE Trial. Am J Obstet Gynecol 2019; 221: B2.
4.
Alfirevic Z Keeney E, Dowswell T, Welton NJ, Medley N, Dias S, Jones LV, Gyte G, Caldwell DM. Which method is best for the induction of labour? A systematic review, network meta-analysis and cost-effectiveness analysis. Health Technol Assess 2016; 20: 1-584.
5.
Thomas J, Fairclough A, Kavanagh J, Kelly AJ. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev 2014; 2014: CD003101.
6.
Miller H, Goetzl L, Wing DA, Powers B, Rugarn O. Optimising daytime deliveries when inducing labour using prostaglandin vaginal inserts. J Matern Fetal Neonatal Med 2016; 29: 517-522.
7.
Bishop EH. Pelvic scoring for elective induction. Obstet Gynecol 1964; 24: 266-268.
8.
Cunningham FG, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM, Spong CY. Williams Obstetrics, 24e. Columbus 2014.
9.
Meier K, Parrish J, D’Souza R. Prediction models for determining the success of labor induction: a systematic review. Acta Obstet Gynecol Scand 2019; 98: 1100-1112.
10.
Gee H, Taylor EW, Hancox R. A model for the generation of intra-uterine pressure in the human parturient uterus which demonstrates the critical role of the cervix. J Theor Biol 1988; 133: 281-291.
11.
Mlodawski J, Mlodawska Ma, Galuszewska J, Glijer K, Gluszek S. Is unfavourable cervix prior to labor induction risk for adverse obstetrical outcome in time of universal ripening agents usage? single center retrospective observational study. J Pregnancy 2020; 2020: 4985693.
12.
Creasy and Resnik’s Maternal-Fetal Medicine: Principles and Practice. 8th edition. Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore TR, Greene MF. Elsevier, Inc. 2019.
13.
Rokita W, Mlodawski J. Vaginal birth after caesarean section-qualification, outcomes and complications. Varia Medica 2018; 2: 192-200.
14.
Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP. Risk of uterine rupture during labor among women with a prior cesarean delivery. N Engl J Med 2001; 345: 3-8.
15.
Wing DA, Lovett K, Paul RH. Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstet Gynecol 1998; 91: 828-830.
16.
Practice Bulletin No. 184 Summary: Vaginal Birth After Cesarean. Obstet Gynecol 2017; 130: 1167-1169.
17.
NICE Guidance. Inducing labour. Clinical guideline CG70. July 2008.https://www.nice.org.uk/guidan... (Accessed on January 03 2020).
18.
Bouchghoul H, Zeino S, Houllier M, Senat MV. Cervical ripening by prostaglandin E2 in patients with a previous cesarean section. J Gynecol Obstet Hum Reprod 2020; 49: 101699.
19.
Vecchioli E, Cordier AG, Chantry A, Benachi A, Monier I. Maternal and neonatal outcomes associated with induction of labor after one previous cesarean delivery: a French retrospective study. PLoS One 2020; 15: e0237132.
20.
Choo SN, Kanneganti A, Abdul Aziz MNDB, Loh L, Hargreaves C, Gopal V, Biswas A, Chan YH, Ismail IS, Chi C, Mattar C. Mechanical dilatation of the cervix in a scarred uterus: the study protocol of a randomised controlled trial comparing a single cervical catheter balloon and prostaglandin PGE2 for cervical ripening and labour induction following caesarean delivery. BMJ Open 2019; 9: e028896.
21.
Bomba-Opoń D, Drews K, Huras H, Laudański P, Paszkowski T, Wielgoś M. Polish Gynecological Society Recommendations for Labor Induction. Ginekol Pol 2017; 88: 224-234.
22.
Ferring Pharmaceuticals Inc. Cervidil (dinoprostone vaginal insert): US prescribing information. http://www.ferringusa.com [accessed 11.03.2021].
23.
Smyth E, Burke A, FitzGerald GA. Lipid-derived autacoids: eicosanoids and platelet-activating factor. In: Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 11e. Brunton L, Lazo J, Parker K (eds.). The McGraw-Hill Companies, Inc. 2005.
24.
gel Prepidil® Gel dinoprostone cervical. https://www.accessdata.fda.gov.... [Online] [acessed: 01 08 2020.].
25.
(dinoprostone) FDA-Approved Drugs: Cervidil®. https://www.accessdata.fda.gov.... [Online] [acessed 13 03 2021].
26.
Bomba-Opoń D, Drews K, Huras H, Laudański P, Paszkowski T, Wielgoś M. Labor induction – clinical algorithms. Polish Society of Gynecologists. Ginekol Perinatol Prakt 2017; 2: 58-71.
27.
Misodel 200, drug characteristics. pub.rejestrymedyczne.csioz.gov.pl. [Online] Ferring Pharmaceuticals Poland, 11.01.2018.
28.
Charakterystyka produktu leczniczego. http://chpl.com.pl/data_files/.... Cytotec, 200 µg. [Online].
29.
Kemper JI, Li W, Goni S, Flanagan M, Weeks A, Alfirevic Z, Bracken H, Mundle S, Goonewardene M, Ten Eikelder M, Bloemenkamp K, Rengerink KO, Kruit H, Mol BW, Palmer KR. Foley catheter vs oral misoprostol for induction of labor: individual participant data meta-analysis. Ultrasound Obstet Gynecol 2021; 57: 215-223.
30.
Wing DA, Brown R, Plante LA, Miller H, Rugarn O, Powers BL. Misoprostol vaginal insert and time to vaginal delivery: a randomized controlled trial. Obstet Gynecol 2013; 122: 201-209.
31.
Mlodawski J, Mlodawska M, Plusajska J, Galuszewska J, Glijer K, Gluszek S. Misoprostol vaginal insert and Foley catheter in labour induction – single center retrospective observational study of obstetrical outcome. Ginekol Pol 2020; 91: 700-703.
32.
Wing DA; Misoprostol Vaginal Insert Consortium. Misoprostol vaginal insert compared with dinoprostone vaginal insert: a randomized controlled trial. Obst Gynecol 2008; 112: 801-812.
33.
Blanc-Petitjean P, Salomé M, Dupont C, Crenn-Hebert C, Gaudineau A, Perrotte F, Raynal P, Clouqueur E, Beucher G, Carbonne B, Goffinet F, Le Ray C. Labour induction practices in France: a population-based declarative survey in 94 maternity units. J Gynecol Obstet Hum Reprod 2018; 47: 57-62.
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
